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a b s t r a c t
Here we investigated the protective role of caffeic acid phenyl ester (CAPE) on erythro-
cyte indices and osmotic resistance, blood coagulation, hepato-renal function and antio-
xidant status in cadmium (Cd) toxicity in rats. Cd intoxication was induced by intraperi-
toneal injection (i.p.) of cadmium chloride (1 mg/kg/day) for 21 days, and CAPE was daily
given (10 mmol/kg; i.p.) also for 21 days. At day 22, blood samples, livers and kidneys
were prepared for screening of: (1) erythrocyte indices: red blood cell (RBC) count, osmo-
tic fragility, hemoglobin (HGB) concentration, hematocrit (HCT), mean corpuscular
volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin
concentration (MCHC); (2) blood coagulation tests: prothrombin time (PT), activated par-
tial thromboplastin time (APTT), and fibrinogen (FIB) level; (3) serum levels of liver and
kidney function biomarkers (aspartate aminotransferase, alanine aminotransferase, alka-
line phosphatase, albumin, creatinine and blood urea nitrogen); (4) blood, liver and kid-
ney levels of Cd; and (5) serum and hepato-renal concentrations of glutathione (GSH),
superoxide dismutase (SOD), and thiobarbituric acid reactive substances (TBARS). Cd
intoxication significantly impaired hepato-renal function, prolonged PT and APTT, redu-
ced FIB, decreased RBC count and osmoresistnacy as well as the values of HGB, HCT,
MCV, MCH and MCHC. Interestingly, therapy with CAPE successfully eliminated Cd and
significantly stabilized erythrocyte indices, blood coagulability and hepato-renal functio-
nal status in Cd-intoxication. Additionally, CAPE therapy significantly reversed the dec-
reases in GSH and SOD, and the increases in TBARs that were induced by Cd intoxica-
tion. In conclusion, CAPE can represent a promising therapeutic agent in eliminating Cd
and counteracting its hematological, hemostasis and hepatorenal toxic effects.
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Caffeic acid phenyl ester (CAPE) is one of the main medic-
inal components of honeybee propolis that possesses a
variety of biological and pharmacological actions such as
potent free radical scavenging, antioxidant, anti-inflamma-
tory, cytoprotective, immunomodulatory, antiviral and pro-
mising anticancer properties [1]. Recently, the ameliorating
effects of CAPE on different disease modalities of hematolo-
gical, blood coagulation and vascular abnormalities have
also been emerged. In this concept, CAPE had shown to
ameliorate blood coagulation abnormalities and disturbed
oxidative stress in endotoxic model of acute liver failure [2],
increase cerebral blood flow and improve ischemic stroke in
neurovascular disease [3], protect peripheral blood mono-
nuclear cells against hyperthermal stress [4], prevent drugs
to induce toxic and damage effects on red blood cells (RBCs)
[5], and potently inhibit the synthesis of inflammatory and
atherosclerotic leukotrienes in human polymorphonuclear
leukocytes and whole blood [6].
Cadmium (Cd) is classified as a very harmful environ-
mental pollutant to the humans that transfers between
various levels of the food chain [7]. Occupational exposure
to the Cd and its compounds primarily occurs in mining,
smelting, processing, and battery manufacturing. In addi-
tion, environmental and non-occupational exposures come
from various foods, contaminated water, contaminated dust
and tobacco smoke [8]. Though the definite mechanisms of
its associated toxicity are not yet well covered, it has been
revealed that Cd markedly stimulates the formation of
reactive oxygen species (ROS), enhances lipid peroxidation,
cell membrane damage, and depletes the antioxidant
defense elements in different body organs [9]. It has been
proved that after exposure, Cd enters the blood and binds to
the erythrocyte membranes and blood albumin, and then is
transported to liver, where it bounds to metallothionein
(MT) [10]. The Cd–MT complex is then released back into
circulation [10], and accumulates in the blood system,
kidney, liver, lung, testis, brain, and bone [11]. In the blood
and tissues, Cd stimulates the formation of ROS, thus
causing oxidative damage, which result in a loss of cell
membrane functions [12], multi-organ damage and impor-
tant hematological alterations [13, 14].
Over the past decade, a variety of research studies have
reported that medications with free-radical scavengers and
antioxidants are useful in protecting against Cd toxicity [7,
14, 15]. To date, few studies have shown the remarkable
tissue protective effects of CAPE against Cd intoxication. In
this regard, therapy with CAPE had significantly resulted not
only in elimination of Cd from blood and tissues but also in
preventing Cd-induced oxidative stress, overproduction of
ROS, impaired cellular ultrastructures, and injuries in the
renal, cardiac and liver tissues [9, 16–18]. However, the
possible preventative effect of CAPE against the hematologi-
cal and blood coagulation dysfunctions secondary to Cd
intoxication is still not well investigated. Coherently, the
present study aimed to investigate the possible alleviating
effects of CAPE on the altered hematological, erythrocyte




Cadmium chloride (CdCl2) and caffeic acid phenethyl ester
(CAPE) were purchased from Sigma–Aldrich Chemical Com-
pany (St. Louis, MO, USA). Commercial assay kits of total
reduced glutathione (GSH) content, superoxide dismutase
(SOD) activity, and thiobarbituric acid reactive substances
(TBARS) concentration were purchased from Cayman Che-
mical (Ann Arbor, MI, USA). All other used chemicals and
reagents were of analytical grade and obtained from stan-
dard commercial supplies as stated under the sections of
their applications.
Animals, treatments and experimental approach
Forty adult male Wistar albino rats, weighing 230–250 g,
were used in the present study. The rats were housed five
per cage under controlled temperature (20–25 8C) and 12-h
light–dark cycle, and allowed free access to water and
a commercial rat pellets stock diet. All experimental proto-
cols were approved by the Committee for the Care and Use
of Laboratory Animals at Umm Al-Qura University, KSA, and
all animals received care according to the criteria outlined
in the Guide for the Care and Use of Laboratory Animals
prepared by the National Academy of Sciences and pub-
lished by the National Institutes of Health. The rats were
randomly divided into 3 experimental groups: control group
(n = 10), Cd-group (n = 15), and Cd plus CAPE group (n = 15).
In Cd and Cd + CAPE groups, CdCl2, dissolved in physiologi-
cal saline (0.9% sodium chloride (NaCl) in distilled water),
was intraperitoneally injected at a dose of 1 mg/kg/day for
21 days, and in Cd + CAPE group, CAPE was co-administered
i.p. at a dose of 10 mmol/kg for also 21 days. The doses of
both Cd and CAPE were chosen on the basic of previous
studies [2, 9, 16]. Control rats were received only with
physiological saline. At the end of the study (i.e. at day 22),
all animal groups were fasted for 12 h and then sacrificed
under ether anesthesia and their blood specimens were
collected. After blood withdrawal, the livers and kidneys
were harvested quickly, and divided into two portions:
a portion was weighed and quickly stored at 80 8C until Cd
measurement, while the second one was homogenized in
RIPA lysis buffer (1:6 w:v), centrifuged at 10 000 rpm for
10 min at 4 8C, and its supernatant was stored at 80 8C
until used for measurement the intra-hepatic and intra-
renal concentrations of antioxidant and oxidative stress
biomarkers as described below.
Blood sample analysis
During scarification process, four blood samples were imme-
diately withdrawn from the vena cava of each rat and used
for blood coagulation, hematology and biochemical ana-
lyses.
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0.11 M sodium citrate anticoagulant (1:9, v:v), and used for
plasma preparation for screening of the following blood
coagulation tests: prothrombin time (PT), activated partial
thromboplastin time (APTT), and fibrinogen (FIB) concentra-
tions, by using Dade® Behring reagents and following
manufacturer's instructions as previously described [19].
The second sample was collected in a tube contained
disodium salt of ethylene diamine tetra acetic acid (EDTA)
anticoagulant and used for determination of the following
hematology parameters: counts of RBCs, white blood cells
(WBCs) and platelets (PLTs), hemoglobin (HGB) concentra-
tion, hematocrit (HCT), mean corpuscular volume (MCV),
mean corpuscular hemoglobin (MCH) and mean corpuscular
hemoglobin concentration (MCHC). These hematological
parameters were determined by standard hematological
techniques.
The third sample was collected into a heparinized test
tube and used for determination of erythrocyte osmotic
fragility according to the method described previously by
Azeez et al. [20] and Mineo et al. [21]. Briefly, 0.02 ml of
blood of each rat was transferred into microtubes containing
one ml of increasing concentration of phosphate-buffered
NaCl solution (0.0, 0.1, 0.3, 0.5, 0.7, and 0.9%) at pH 7.4. The
microtubes were then gently mixed, incubated at room
temperature for 30 min, and then centrifuged at 2000 rpm
for 15 min. The supernatant (200 ml) of each microtube was
decanted into 96-well micro-plate, and its optical density
was determined spectrophotometrically at 540 nm (Micro-
plate reader, Bio-Rad Laboratories). The percentage of RBC
hemolysis in each NaCl concentration was determined,
using hemolysis in distilled water (0.0% NaCl) as the
maximum percentage. The higher hemolysis occurs, the
greater is osmotic fragility of RBC [20, 21].
The last portion of the collected blood was placed in a plain
centrifuge tube without any anticoagulant and after centrifuga-
tion process, its corresponding serum was obtained and used
for measurement the sera concentrations of Cd and biomarkers
of antioxidation and oxidative stress as described below.Table I – Hematological and blood coagulation findings
Parameter Units Control group (n = 10) 
WBC 103/ml 11.92  0.79 
RBC 106/ml 8.67  0.48 
HGB g/l 157.67  7.23 
HCT % 48.33  0.71 
MCV fL 64.27  0.84 
MCH pg 22.13  1.65 
MCHC g/l 344.42  39.50 
PLT 103/ml 1000.27  91.83 
PT Second 12.82  1.37 
APTT Second 21.73  3.46 
FIB mg/dl 263.90  33.77 
The values are presented as means  SD. (Cd) cadmium, (CAPE) caffeic a
hemoglobin, (HCT) hematocrit, (MCV) mean corpuscular volume, (MCH) m
concentration, (PLT) platelet, (PT) prothrombin time, (APTT) activated pa
* P < 0.05 versus control group.
# P < .05 versus Cd group.Biochemical analysis of hepato-renal function
The prepared sera samples were employed for measurement
of the serum concentrations of liver function enzymes
(aspartate aminotransferase (AST), alanine aminotransferase
(ALT) and alkaline phosphatase (ALP)), albumin (ALB), and
kidney function biomarkers (serum creatinine (CRE) and
blood urea nitrogen (BUN)).
Evaluation of antioxidant and oxidative stress status
The levels of total reduced GSH and activities of SOD (as
indices of non-enzymatic and enzymatic antioxidant sta-
tus, respectively) were measured in the serum and homo-
genates of the liver and kidney tissues. On the other
hand, the concentrations of TBARS, indices of lipid perox-
idation and oxidative stress, were also determined in
these sera, liver and renal biological samples. During
these three assays, specific commercial kits (Cayman
Chemical; Ann Arbor, MI, USA) were used, and all samples
were processed in duplicate and according the manufac-
turer's instructions.
Measurement of blood, hepatic and renal cadmium content
Cd levels in the blood, liver, and kidneys were determined
as described in previous studies [22, 23]. For assessment of
Cd levels in blood, 0.5 ml whole blood samples were used,
while for its assessment in tissues, constant weight slices of
livers and kidneys were oven dried at 60 8C. The blood
samples and the dried tissues (100 mg from each sample)
were digested with 3 ml trace pure concentric nitric acid on
a hot plate at 120 8C. Once the digestion was complete, the
samples were cooled at room temperature and their
volumes were then adjusted to 10 ml with deionized water.
Cd concentration was quantified by using an atomic absorp-
tion spectrophotometer (Perkin-Elmer AAnalyst 100). Cd
concentration is expressed as mg/ml blood and mg/g liver or
kidney tissue weight.Cd group (n = 15) Cd + CAPE group (n = 15)
13.53  2.72 12.27  1.46
5.93  0.83* 8.10  0.16#
115.46  6.03* 151.67  3.51#
41.83  1.00* 46.13  1.01#
52.87  4.48* 60.20  1.54#
16.70  1.11* 20.40  1.20#
300.26  27.77* 337.67  38.50#
775.32  59.61* 933.36  70.76#
43.14  4.33* 17.76  2.33#
77.52  13.43* 29.36  5.21#
93.37  9.37* 226.68  42.23#
cid phenyl ester, (WBC) white blood cell, (RBC) red blood cell, (HGB)
ean corpuscular hemoglobin, (MCHC) mean corpuscular hemoglobin
rtial thromboplastin time, and (FIB) fibrinogen.
Table II – Erythrocyte osmotic fragility
Group Hemolysis of RBC (%)
0.0% NaCl 0.1% NaCl 0.3% NaCl 0.5% NaCl 0.7% NaCl 0.9% NaCl
Control (n = 10) 87.7  3.2 80.5  4.5 65.5  7.1 33.5  5.6 13.3  3.3 2.1  0.3
Cd (n = 15) 97.3  2.2* 93.3  4.3* 85.3  5.2* 55.7  7.4* 38.4  3.5* 21.5  1.3*
Cd + CAPE (n = 15) 89.3  7.4# 84.5  3.6# 68.5  2.7# 37.5  2.1# 17.7  2.2# 3.5  0.7#
(Cd) cadmium, (CAPE) caffeic acid phenyl ester.
* P < 0.05 versus control group.
# P < 0.05 versus Cd group.
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The results were expressed as the mean  standard deviation
(SD) and statistical analysis was carried out using SPSS
software, version 16.0 (SPSS Inc., Chicago, IL, USA). Differences
among the groups were investigated using one-way analysis
of variance (ANOVA) followed by a Student's t-test. Differ-
ences between percentages of RBC hemolysis for determina-
tion of osmotic fragility for the groups were analyzed by x2
test. A P value of <0.05 was considered statistically significant.
Results
Hematological and blood coagulation findings
The hematological and blood coagulation changes are shown
in Table I. Compared with the control group, Cd-group had
showed significant decreases in RBC and PLT counts, but not
in WBC counts. Moreover, the values of HGB, HCT, MCV,
MCH, and MCHC had significantly decreased in Cd-group in
comparison with their values in the normal controls. In
contrary, therapy with CAPE had successfully ameliorated
these hematological toxic effects of Cd, whereby the counts
of RBCs and PLTs, as well as the values of HGB, HCT, MCV,
MCH, and MCHC had showed no significant differences than
those of normal control rats. Intoxication with Cd had also
resulted in significant deteriorations on blood coagulation. As
demonstrated in Table I, there were significant prolongation
of PT and APTT clotting tests associated with significantly
decreased FIB levels in Cd-group, when compared with
control group. By contrast, treatment of these Cd-injected rats
with CAPE had significantly succeeded in improvement of theTable III – Serum levels of liver and kidney function biomarker
Parameter Units Control group (n = 10) 
AST IU/l 109.00  12.17 
ALT IU/l 49.17  3.27 
ALP IU/l 206.33  20.79 
ALB g/dl 4.33  0.59 
CRE mg/dl 0.26  0.04 
BUN mg/dl 47.36  9.12 
The values are presented as means  SD. (Cd) cadmium, (CAPE) caffeic
aminotransferase, (ALP) alkaline phosphatase (ALP), (ALB) albumin, (CRE
* P < 0.05 versus control group.
# P < 0.05 versus Cd group.values of PT APTT, and FIB (Table I). Collectively, this part of
the results indicates that Cd intoxication in rats is associated
with important alterations in their hematological and blood
coagulation parameters and these alterations were remark-
ably alleviated by CAPE therapy.
Effects on erythrocyte osmotic fragility
Changes in RBCs hemolytic pattern after their exposed to
different concentrations of NaCl solution were measured to
determine the erythrocyte osmotic fragility of all animal
groups. As shown in Table II, the osmotic fragility of RBCs of
Cd group was significantly higher than that of Cd + CAPE
and normal control groups at each tested NaCl solution.
This in turn reflects the stabilizing effect of CAPE therapy
on RBC osmotic resistance.
Biochemical findings
The results of serum biochemistry reflect that both the
hepatic and renal function of rats had been altered due to
Cd intoxication and these damaging effects of Cd had been
attenuated by CAPE therapy. As shown in Table III com-
pared with the control group, significant changes in the
serum levels of AST, ALT, ALP, and ALB (as biomarkers of
liver function), as well as the serum levels of CRE and BUN
(as biomarkers of renal function) were detected only in Cd
group but not in Cd + CAPE group.
Blood, renal and hepatic levels of cadmium
Next, we confirmed the accumulation of administered Cd in
the blood and hepato-renal tissues of the rats (Fig. 1). After 21s
Cd group (n = 15) Cd + CAPE group (n = 15)
571.33  72.29* 163.00  14.93#
136.07  21.06* 73.33  11.35#
274.33  25.14* 211.33  17.35#
2.86  0.38* 4.01  0.27#
0.41  0.34* 0.29  0.01#
63.65  13.44* 49.22  10.10#
 acid phenyl ester, (AST) aspartate aminotransferase, (ALT) alanine
) creatinine, and (BUN) blood urea nitrogen.
Fig. 1 – Effect of caffeic acid phenyl ester (CAPE) therapy on
cadmium (Cd) levels in blood and hepato-renal tissues after
21 days of treatment. *P < 0.001 versus control group;
#P < 0.01 versus Cd group
Table IV – Antioxidant and lipid peroxidation status in serum 
Group GSH (mmol/mg protein) SOD (U
Serum Liver Kidney Serum L
Control (n = 10) 13.7  3.1 69.9  7.3 57.7  9.2 3.8  0.6 289.
Cd (n = 15) 4.7  0.9* 11.7  1.2* 13.74  1.7* 1.2  0.2* 64.
Cd + CAPE (n = 15) 12.2  1.2# 75.9  11.4# 68.7  10.2# 3.3  0.8# 305.
The values are presented as means  SD. (Cd) cadmium, (CAPE) caffeic ac
and (TBARS) thiobarbituric acid reactive substances.
* P < 0.05 versus control group.
# P < 0.05 versus Cd group.
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of Cd group. On the contrary, concurrent administration of
CAPE significantly eliminated Cd from these biological tissues.
Serum, renal and hepatic levels of GSH, SOD and TBARS
Finally, we measured the levels of GSH (an example of non-
enzymatic antioxidant defense mechanism), activities of SOD (an
example of enzymatic antioxidant defense mechanism), and
concentrations of TBARS (an index of lipid perioxidation and
oxidative stress) in the sera samples and the liver and kidney
tissue homogenates of all animal groups. As demonstrated in
Table IV, Cd intoxication in rats had associated with significant
reduction in GSH content and SOD activity, as well as marked
elevation in TBARS content in the sera, livers and kidneys of Cd
group. On the other hand, concurrent administration of CAPE
with Cd had obviously counteracted these effects of Cd on GSH,
SOD, and TBARS in all tested biological samples.
Discussion
Cd is classified as a major industrial and environmental
pollutant that raises serious public health concerns worldwide
because of its high toxic effects on human and animals [8].
CAPE is a biological active component of honeybee propolis
extracts with pluripotent pharmacological actions and potent
antioxidant activity [9]. This study was designed to investigate
the effect of CAPE supplementation therapy on erythrocyte
indices, blood coagulation, hepato-renal functional and antiox-
idant status in Cd intoxication in rats. The results showed that
CAPE therapy not only eliminated the heavy metal but also and
importantly resulted in an obvious protection against Cd-
induced marked hematological and blood hemostasis distur-
bances, hepato-renal injury and oxidative stress in rats.
There is a compelling body of evidence that Cd exposure
importantly contributes to human and animal liver and
kidney diseases [24, 25]. After the intake and resorption, Cd
enters the blood and binds to the erythrocyte membranes
and plasma albumin [26]. In the blood and tissues, Cd
stimulates lipid peroxidation and the formation of ROS, thus
causing oxidative cellular and tissue damages [10, 12, 13]. In
support, Cd was detected at high concentrations in the blood,
liver and kidneys of Cd group (Fig. 1), and this accumulation
pattern of Cd was significantly attenuated with CAPE therapy.
Moreover, the biochemical findings (Table III) revealed the
occurrence of hepato-renal impairment in Cd-exposed animalsand hepato-renal tissues
/mg protein) TBARS (nmol/mg protein)
iver Kidney Serum Liver Kidney
5  37.3 267.7  23.4 27.4  4.2 48.6  6.2 37.4  5.9
8  8.2* 71.5  6.7* 116.2  23.4* 1019.5  195.9* 1113.3  195.9*
3  50.5# 311.5  47.8# 36.74  5.8# 87.2  14.6# 118.6  23.29#
id phenyl ester, (GSH) total glutathione, (SOD) superoxide dismutase,
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elevations in the serum levels of AST, ALT, ALP, CRE and BUN
[27]. The observed hepato-renal protective effects of CAPE against
Cd were also accompanied with preventing Cd to induce lipid
peroxidation and decrease antioxidant defense system (Table
IV). Taken together, these findings can reinforce those previously
reported that CAPE has a potent protective effect against renal,
liver, and other body organ injuries caused by Cd intoxication,
and this might be by eliminating Cd and inhibiting Cd-induced
oxidative stress and tissue damage [9, 16–18].
Hematopoietic system is one of the most sensitive systems
to evaluate the hazards effects of poisons and drugs in humans
and animals [27]. In consistency, the current study indicated
that an exposure to toxic Cd was associated with significant
disturbances in erythrocyte indices; and therapy with CAPE had
successfully alleviated these hematological changes induced by
Cd (Table I). In this regard, anemia was clearly observed in rats
received Cd alone but not in those received Cd plus CAPE. In
agreement, it has been approved that Cd accumulation in
kidney, liver and spleen can suppress the activity of these
important hematopoietic tissues [28]. Additionally, some pre-
vious studies revealed that exposure to Cd induces anemia
associated with decrease in RBCs counts, HGB concentration,
HCT value, and induction of oxidative damage and lipid
peroxidation in blood and RBCs [13, 14, 29, 30]. Moreover, the
decreases that were observed her in the values of MCV, MCH,
and MCHC in Cd group but not in Cd + CAPE group can also
indicate the further ability of Cd intoxication to induce micro-
cytic hypochromic anemia [25], and this effect was also
alleviated by CAPE therapy. Furthermore, data of erythrocyte
osmotic fragility test (Table II); which is a test refers to the
propensity of erythrocytes to hemolyse when they are sub-
jected to osmotic stress by being placed in a hypotonic solution
[20, 21], demonstrated that exposure to Cd had resulted in
a significant increase in RBC osmofragility and this effect was
significantly improved by CAPE treatment (Table II). Recent
reports revealed that the enhanced oxidative stress and
decreased antioxidant status result in increased erythrocyte
deformability, easier RBC membrane lipoperoxidability  and
damage, and consequently, an increased osmotic fragility and
shortened life-span [20, 21]. As the powerful free radical
scavenger and antioxidant properties of CAPE have been
reported in the present study and by previous researchers [2,
31, 32], it can be considered that a portion of the stabilizing
effect of CAPE therapy on rat's RBC osmotic resistance could be
attributed to its antioxidant activity. Collectively, Cd intoxica-
tion might lead to anemia as a result of either suppression the
activity of hematopoietic tissues, impaired erythropoiesis,
accelerated erythroclasia because of the altered RBCs mem-
brane permeability, increased RBCs mechanical fragility, and/or
defective Fe metabolism [25].
Data of blood clotting tests (Table I) demonstrated that
exposure to Cd had resulted in a significant hypocoagulation
state in form of marked prolongation of the coagulation tests
PT, APTT, low PT count and decreased FIB levels-And, this
Cd's hemostatic dysregulation effect was significantly
improved by CAPE treatment. It is well known that the liver is
the major organ for synthesis of procoagualtion factors and
substances. Thus, the hypocoagulation state that was
observed her in Cd group but not in Cd + CAPE group might berelated to Cd-induced liver injury with decreased production
of the procoagulation factors and reduced hepatic clearance
of plasminogen activators leaded to enhanced fibrinolytic
activity [2, 33]. These findings and its related suggestion can
also be supported by Korish's report [2] that therapy with
CAFÉ protects the liver and prevents the hemostatic altera-
tions in endotoxic-induced acute liver failure.
Earlier studies had indicated that treatment with free-
radical scavengers and antioxidants are useful in protecting
against Cd toxicity [7, 14, 15]. Therefore, depletion of anti-
oxidative defense mechanism (represented by decreased SOD
and GSH) together with increased TBARs (an index of lipid
peroxidation and oxidative stress) that were observed here in
the serum, liver and kidney tissues of Cd-injected rats but not
of Cd-injected/CAPE-treated rats (Table IV) could be the main
underlying pathogenic mechanisms by which the injected
Cd had induced its hematological and organ toxicity [9, 14].
Similarly, the preventative effects of CAPE that were also
observed against Cd could also be attributed to its potent
antioxidant property [2, 32]. In harmony, Gokalp et al. [5]
showed the cytoprotective ability of CAPE in preventing
anti-TB drug ‘‘isoniazed’’ to induce oxidative damage in
RBCs, and the potent renoprotective effect of CAPE against
Cd-induced injury has been previously confirmed and
attributed mainly to the antioxidant activity of CAPE [9, 16–
18]. Finally, by increasing the antioxidant elements and
inhibiting the oxidative status, CAPE had shown to protect
the brain vasculature from ischemic stroke disease [3], and
protect the liver and improve blood coagulation abnormal-
ities in endotoxic model of acute liver failure [2].
Conclusion
Based on the presented results, it can be concluded that Cd
intoxication was resulted in impaired erythrocyte indices,
erythrocyte osmotic resistance blood coagulability, and
hepato-renal function in rats, and this might be due to
enhancing of lipid peroxide concentration and/or depletion
of the activity of antioxidant defense elements. By contrast,
CAPE supplementation therapy was resulted in favorable
effects in eliminating Cd and preventing the hematological,
blood coagulation, and hepato-renal disturbances that
occurred secondary to Cd intoxication. Moreover, CAPE
therapy was also resulted in restoring the antioxidant
activity and inhibiting lipid peroxidation in both blood and
organs. Therefore, CAPE could be a promising agent for the
treatment of Cd intoxication; however, further studies are
crucially needed to improve this treatment in patients.
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